Zhang et al. reported that TMED3 enhanced cell viability and migration and inhibited apoptosis in chordoma cells by greatly silencing TMED3 expression and activation, suggesting that TMED3 may be a novel target for tumor therapy [11]. The gene discussed is TMED3; the disease is chordoma.